Annual Drug Patent Expirations for ZEMBRACE+SYMTOUCH
Zembrace Symtouch is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.
ZEMBRACE SYMTOUCH drug price trends.
This drug has six patent family members in six countries.
The generic ingredient in ZEMBRACE SYMTOUCH is sumatriptan succinate. Two suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
